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Abstract
Background:  The structure, function and reaction mechanism of glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) have been extensively studied. Based on these studies, three anion binding sites
have been identified, one 'Ps' site (for binding the C-3 phosphate of the substrate) and two sites, 'Pi' and
'new Pi', for inorganic phosphate. According to the original flip-flop model, the substrate phosphate group
switches from the 'Pi' to the 'Ps' site during the multistep reaction. In light of the discovery of the 'new Pi'
site, a modified flip-flop mechanism, in which the C-3 phosphate of the substrate binds to the 'new Pi' site
and flips to the 'Ps' site before the hydride transfer, was proposed. An alternative model based on a
number of structures of B. stearothermophilus GAPDH ternary complexes (non-covalent and thioacyl
intermediate) proposes that in the ternary Michaelis complex the C-3 phosphate binds to the 'Ps' site and
flips from the 'Ps' to the 'new Pi' site during or after the redox step.
Results: We determined the crystal structure of Cryptosporidium parvum GAPDH in the apo and holo
(enzyme + NAD) state and the structure of the ternary enzyme-cofactor-substrate complex using an
active site mutant enzyme. The C. parvum GAPDH complex was prepared by pre-incubating the enzyme
with substrate and cofactor, thereby allowing free movement of the protein structure and substrate
molecules during their initial encounter. Sulfate and phosphate ions were excluded from purification and
crystallization steps. The quality of the electron density map at 2Å resolution allowed unambiguous
positioning of the substrate. In three subunits of the homotetramer the C-3 phosphate group of the non-
covalently bound substrate is in the 'new Pi' site. A concomitant movement of the phosphate binding loop
is observed in these three subunits. In the fourth subunit the C-3 phosphate occupies an unexpected site
not seen before and the phosphate binding loop remains in the substrate-free conformation. Orientation
of the substrate with respect to the active site histidine and serine (in the mutant enzyme) also varies in
different subunits.
Conclusion: The structures of the C. parvum GAPDH ternary complex and other GAPDH complexes
demonstrate the plasticity of the substrate binding site. We propose that the active site of GAPDH can
accommodate the substrate in multiple conformations at multiple locations during the initial encounter.
However, the C-3 phosphate group clearly prefers the 'new Pi' site for initial binding in the active site.
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Background
Protozoan parasite Cryptosporidium parvum is a common
cause of water-borne diseases throughout the world [1].
There is no effective anti-cryptosporidial therapy [2,3].
Cryptosporidium infection can be lethal in immunocom-
promised individuals, and therefore it poses a particularly
serious problem in patients with AIDS [4]. Despite the
urgent need for identification of novel drug targets, very
little is known about the metabolic enzymes of this rela-
tively newly recognized human pathogen. The parasite
apparently relies mainly on the anaerobic oxidation of
glucose for energy production [5-8]. Therefore, glycolytic
enzymes are of considerable interest as possible targets for
anti-cryptosporidial drugs. One glycolytic enzyme, the
glyceraldehyde 3-phosphate dehydrogenase (GAPDH),
has been considered a candidate for inhibition of proto-
zoan parasites [9,10]. By exploiting the differences in the
structure of the parasitic and human GAPDH, specific
inhibitors of trypanosomatid GAPDH have been designed
[11]. However, the Cryptosporidium enzyme has not
been characterized previously.
GAPDH plays an essential role in glycolysis by catalyzing
the reversible two step oxidative phosphorylation of D-
glyceraldehyde 3-phosphate (D-G3H) into 1,3-diphos-
phoglycerate using NAD (or NADP) as a cofactor [12]. In
the first step D-G3H is covalently attached to the active
site cysteine residue via nucleophilic attack on the carbo-
nyl group of D-G3H, resulting in the formation of a thio-
hemiacetal intermediate. This is followed by a hydride
transfer from the thiohemiacetal to NAD, leading to the
formation of a thioacyl enzyme. Finally, the resulting
thioester is phosphorylated through the nucleophilic
attack of an inorganic phosphate ion (Pi) on the carbonyl
carbon atom of the thioacyl group, which leads to the for-
mation of 1,3-diphosphoglycerate.
The three-dimensional structures of GAPDH from a
number of mammalian, bacterial and parasitic species
have been determined [13-20]. GAPDHs exist as a
homotetrameric protein. Based on the location of sulfate
ions originating from the crystallization medium, two
anion binding sites were initially identified in each
GAPDH subunit [19,21]. These sites are labeled 'Ps', cor-
responding to the binding site for the C-3 phosphate of D-
G3H, and 'Pi', corresponding to the binding site for the
inorganic phosphate. The 'Ps' site is conserved in various
GAPDH structures. However, two possible 'Pi' sites have
been proposed [17,19]. The original Pi site was identified
in crystals grown from ammonium sulfate solutions and
was based on the position of the sulfate ion [19]. The sec-
ond 'Pi' site was identified by Kim et al [17] in crystals
grown from a phosphate-buffered medium. This latter
site, referred to as the 'new Pi' site, is 2.9 Å from the origi-
nal 'Pi' site.
Skarżyñski et al [19] proposed that the 'Pi' site is the loca-
tion of the inorganic phosphate in the phosphorylation
step. According to their 'flip-flop' hypothesis, the C-3
phosphate of the substrate binds first to the 'Pi' site in the
acylation step and then flips from the 'Pi' to the 'Ps' site
during the phosphorylation step. This mechanism is sup-
ported by kinetic studies [22] as well as structural studies
of the E. coli GAPDH in which the substrate was covalently
linked to the enzyme in a hemiacetal form [16] and there
was no cofactor. The crystal structure of Trypanosoma cruzi
GAPDH covalently bound to a substrate analogue also
provided strong support for this model [14]. In the E. coli
and T. cruzi enzyme structures, the 'Pi' site was localized
to the 'new Pi' site.
However, in the Bacillus stearothermophilus GAPDH
(BsGAPDH) ternary complex with NAD and D-G3H, the
C-3 phosphate group of the non-covalently bound sub-
strate was located in the 'Ps' site, and Didierjean et al [15]
proposed that this structure represented the productive
Michaelis complex. The substrate was found in the same
conformation in two ternary complexes that were pre-
pared by using different active site mutant (Cys→Ala and
Cys→Ser) forms of BsGAPDH. In a recently reported crys-
tal structure of the thioacyl intermediate of wild type
BsGAPDH the C-3 phosphate is found (with partial occu-
pancy) in the 'new Pi' site [23] in each subunit.
We have determined the crystal structure of C. parvum
GAPDH (CpGAPDH) in a substrate free state (apo), in the
NAD-bound state (holo) and in a ternary complex with
NAD and D-G3H. At no stage during purification and
crystallization was the protein exposed to sulfate or phos-
phate ions. As a result there is no sulfate or phosphate ion
in any of the CpGAPDH structures. In order to form the
ternary complex with the physiological substrate, the
nucleophilic cysteine residue of the active site (C153), was
substituted with serine following the strategy employed
by Didierjean et al [15] to form the ternary complex of
BsGAPDH. However, in contrast to their results, in three
subunits of the CpGAPDH tetramer the C-3 phosphate is
located at the 'new Pi' site and not in the 'Ps' site. In the
remaining subunit, an unexpected new binding site for
this phosphate is revealed. According to the accepted
mechanism of enzymatic action the conformation of the
substrate in two subunits (C and D) appears to be unpro-
ductive.
Methods
Expression and purification
We recently reported the expression and purification of
wild type CpGAPDH [24]. Briefly, recombinant
CpGAPDH containing an N-terminal hexa-histidine tag
was expressed in E. coli via induction with 0.4 mM isopro-
pyl thio-β-D-galactoside and growing the culture at roomBMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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temperature for 18 hrs post-induction. The protein was
purified from the bacterial extract using metal affinity
chromatography (Ni-NTA, Qiagen), cation-exchange
chromatography (SP Sepharose, Amersham) and size
exclusion chromatography (Superdex 200, Amersham).
The point mutation (C153 to S) was introduced into the
recombinant plasmid using QuikChange Site-Directed
Mutagenesis kit (Stratagene) according to the manufac-
turer's instructions. The C153S mutant CpGAPDH was
expressed and purified by the same protocol as the wild
type protein.
Enzyme Activity assay
Enzyme activity assay for wild type CpGAPDH was carried
out spectrophotometrically by following the increase in
absorption at λ = 340 nm due to NADH formation. The
reaction mixture contained 1 ml of buffer (50 mM Trieth-
anolamine, 50 mM Na2HPO4, 0.2 mM EDTA, pH 8.8)
and varying concentrations of NAD (10 – 150 μM) and D-
G3H (1.47 – 5.88 mM). DL-G3H (Sigma) contained a
mixture of D- and L-G3H with 50% of the D-isomers. The
reaction was initiated by adding 0.8 μg of purified
CpGAPDH. All measurements were repeated at least three
times. Maximal reaction velocity and Michaelis-Menten
constants, Vmax and Km values, for D-G3H and NAD were
determined from Lineweaver-Burk plots by varying the
concentration of either the substrate or cofactor while the
other was kept constant (2.94 mM D-G3H and 150 μM
NAD).
Crystallization and data collection
Prior to crystallization, purified proteins (both wild type
and the mutant) were concentrated to a final concentra-
tion of 13 mg/ml. No attempt was made to cleave the N-
terminal hexa-histidine tag.
Apo-CpGAPDH
Crystals of wild type apo-CpGAPDH were grown at room
temperature by hanging drop vapor diffusion method
using 16–20% PEG 3000 and 0.2 M NaCl in 0.1 M
HEPES, pH 7.5. Crystals suitable for X-ray diffraction
analysis were reproducibly grown by microseeding tech-
nique using serial dilutions of crushed crystals. X-ray dif-
fraction data were collected at the synchrotron beam line
SBC-19BM at the Advanced Photon Source (APS, Argonne
National Laboratory) on a MAR CCD imaging plate.
Oscillation data were collected at -170°C at a crystal to
detector distance of 200 mm with 1° oscillation/frame
using an X-ray wavelength of 0.9998 Å. For cryo-cooling,
crystals were transferred through a series of cryo-preserva-
tive solutions containing 5, 10, 15, 20 and 25% glycerol
in mother liquor (1 min in each). These crystals belong to
the monoclinic space group P21 with unit cell dimensions
of a = 69.36 Å, b = 121.65 Å, c = 80.00 Å and β = 92.31°.
There are four CpGAPDH subunits per asymmetric unit
(one tetramer), and the value of Vm [25] is 2.33 Å3/Da,
which corresponds to a solvent volume fraction of 47%.
Holo-CpGAPDH
To prepare the holoenzyme (binary complex), wild type
CpGAPDH was incubated with 2 mM NAD for 3 hr on ice
and then crystallized using the same method as for the
apoenzyme. These crystals were isomorphous with the
apo-CpGAPDH crystals. Diffraction data for these crystals
were collected at SBC-19BM beam line on MAR CCD
plate.
Ternary complex (CpGAPDH: NAD: D-G3H)
Crystals of the ternary complex were grown using the
C153S mutant protein under the same conditions
described for the apoenzyme. Prior to crystallization
mutant protein was incubated with 2 mM NAD and 11
mM DL-G3H. X-ray diffraction data were collected at syn-
chrotron beam line SERCAT-22BM (APS, Argonne
National Laboratory). These crystals were also isomor-
phous with the other two forms. Data collection statistics
are summarized in Table 1.
Structure determination and refinement
The structure of the apo-CpGAPDH was solved by molec-
ular replacement, using the entire Trypanosoma cruzi glyco-
somal GAPDH tetramer (1K3T) as the search model [20].
This model gave a clear solution in the rotation and trans-
lation functions, and the electron density maps were of
sufficient quality to allow replacement of non-identical
residues and rebuilding of several regions where there
were deletions compared to the T. cruzi structure. Residues
185–197 could not be modeled due to very weak electron
density in this area. The graphics program COOT was used
for model-building [26].
Since crystals of the holoenzyme and the ternary complex
(the C153S mutant) were isomorphous with those of the
apo-CpGAPDH, the latter structure was simply placed
into the cell for each structure and initially refined by rigid
body techniques. The electron density for the loop con-
taining residues 185–197 was clear in both of these struc-
tures. Difference electron density maps clearly showed the
positions of the NAD molecules in both structures as well
as the positions of the D-G3H molecules in the ternary
complex (see later).
Refinement of the apo and holoenzyme structures was
performed by simulated annealing using CNS [27] with
the stereochemical parameter files defined by Engh and
Huber [28]. No sigma cutoff was applied to the data. Five
percent of the data were randomly selected and removed
prior to refinement for analysis of the free R factor. The
four subunits were restrained by the non-crystallographic
symmetry during most of the refinement. The restraintsBMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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were gradually relaxed as refinement proceeded and
dropped completely at the final stages of refinement. The
progress of the refinements was guided by the decrease in
both the conventional and free R factors. Individual B-fac-
tors were included in the final refinements for each struc-
ture. In case of the ternary complex, after preliminary
refinement of the polypeptide chains, residues S153 and
H180 were mutated to glycine, and difference electron
density maps calculated at this stage allowed us to place
the side chains for these residues as well as the cofactor
and the substrate unambiguously. Attempts to refine
other orientations of the substrate resulted in short con-
tacts and unsuccessful refinement. Refmac5 [29] was used
for further refinement of the structure. Table 1 contains a
summary of the refinement parameters for all three struc-
tures.
Results
Biochemical properties of wild type and mutant 
CpGAPDHs
The presence of the N-terminal hexa-histidine tag allowed
application of metal affinity chromatography for rapid
isolation of recombinant CpGAPDHs (both wild type and
mutant) from E. coli extract in a nearly homogeneous
form. Subsequently ion exchange and size exclusion chro-
matography allowed isolation of a highly purified tetra-
meric protein sample for enzyme kinetic analysis and
crystallization. The apparent Km values for NAD and D-
G3H for wild type CpGAPDH enzyme were estimated to
be 0.032 ± 0.002 and 762.7 ± 43.0 μM, respectively, and
the Vmax is 72 ± 2 μmole/min/mg. The Km value for NAD
is in the same range as for most mammalian GAPDHs but
approximately 10 fold lower than that for parasitic
Table 1: Data collection and refinement statistics.
Apoenzyme Holoenzyme Ternary complex
Crystal data
a (Å) 69.36 69.12 68.00
b (Å) 121.65 121.19 120.10
c (Å) 80.00 80.33 79.28
β (°) 92.31 92.21 92.08
Vm (Å3/Da) 2.33 2.28 2.19
Solvent content (%) 47 46 44
Data collection
Resolution range (Å) 50.0 - 2.2 50.0 - 2.0 20.0 - 2.0
High resolution shell (Å) 2.28–2.2 2.07 - 2.0 2.07-2.0
Reflections 68,051 87,612 84,846
Completeness (%) 98.8 (97.5)* 98.3 (90.4) 99.7 (99.3)
Rsym 0.071 (0.182) 0.068 (0.365) 0.087 (0.309)
Overall I/σ 9.6 8.9 11.9
Refinement
R value 0.203 (0.221) 0.205 (0.240) 0.178 (0.196)
Free R value 0.245 (0.273) 0.238 (0.266) 0.210 (0.254)
Number of protein atoms 9728 10084 10077
Number of hetero atoms 0 176 230
Number of water molecules 405 419 723
Estimated coordinate error 0.25 0.23 0.20
Ramachandran plot (%) (core, allowed, generously allowed, disallowed) 87.6, 11.7, 0.3, 0.4 87.8, 11.6, 0.3, 0.3 89.9, 9.7, 0.1, 0.3
Deviations from ideality
Bond lengths (Å) 0.006 0.006 0.006
Bond angles (°) 1.3 1.3 1.0
Dihedral angles (°) 24.3 23.8 26.8
Improper angles (°) 0.71 0.74 2.41
B-factors (Å2)
All atoms 34.3 32.3 21.9
Protein atoms 34.2 32.1 21.4
NAD N/A 37.9 16.6
D-G3H N/A N/A 36.4
Water molecules 36.8 34.5 29.7
* Values in parentheses refer to the outermost resolution shell.
Rsym = ΣΣ|I - Iι|/ΣI, where I is the mean intensity of the N reflections with intensities Ii and common indices h,k,l.BMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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enzymes from L. mexicana and T. brucei. The Km value for
D-G3H is 3 to 10 fold higher than for mammalian GAP-
DHs and 2 to 3 times lower than respective values for L.
mexicana and T. brucei enzymes [30-33]. As observed with
the BsGAPDH mutant, CpGAPDH C153S mutant pos-
sessed low but definite enzymatic activity [15]. The meas-
ured specific activity of the mutant enzyme was
approximately 450 fold lower than that of the wild type
enzyme.
Overall structure of CpGAPDH
Since the protein containing the hexa-histidine affinity tag
was enzymatically active, no attempt was made to remove
the tag before crystallization. Unlike the GAPDH enzymes
from human placenta [13] and Plasmodium falciparum
[34], the hexa-histidine tag did not impose any difficulty
in obtaining well diffracting crystals of CpGAPDH irre-
spective of substrate and cofactor status.
The overall structure of CpGAPDH is very similar to other
GAPDHs for which structures have been well described, so
this report will focus only on important differences
between CpGAPDH and other GAPDH structures. The
asymmetric unit in the crystal structure contains one
tetramer of CpGAPDH with subunits related by 222 non-
crystallographic symmetry. Each subunit contains seven
α-helices and two β-sheets, one of seven strands and
another with eight. The quality of the structure in all three
crystal forms (apo, holo and ternary complex) was excel-
lent. In all three structures greater than 99% of the resi-
dues are in the allowed (core + allowed) regions of the
Ramachandran plot (Table 1). Only one residue (Val243)
in each subunit (in each structure) has phi/psi angles in a
disallowed region; this residue occurs in a highly con-
served region and assumes a similar conformation in all
known GAPDH structures. The number of water mole-
cules located in the ternary complex was considerably
higher (723) as compared to those in the apo (409) and
holo (418) structures, although the resolution of the
structure (2.0 Å) was identical to that of the holoenzyme.
The average B factor of water molecules in the ternary
complex was also lower than in the other two structures
(see Table 1).
Cofactor binding
The holoenzyme form of CpGAPDH contains one NAD
molecule in each subunit. In some GAPDH holoenzyme
structures NAD is found in only two or three of the four
active sites [13,14,35]. This difference in the composition
has been proposed to result from the cooperativity among
the enzyme subunits. However, in all subunits of the
CpGAPDH holoenzyme structure, NAD molecules are
well ordered with an average B-factor of 38.2 Å2 (for com-
parison, the average B-factor for the protein atoms is 32.3
Å2), suggesting that all four subunits are capable of bind-
ing NAD at the same time at the NAD concentration used
for crystallization. It should be noted that we used 2 mM
NAD for co-crystallization, in comparison to 10 mM used
in the case of human placental enzyme [13], even though
the Km  for NAD is comparable for the human and
CpGAPDH enzymes [32,36].
Cofactor binding induces ordering of the S-loop (residues
185–197) in all four subunits of CpGAPDH (Fig. 1A). In
the apoenzyme this loop, which forms part of the NAD
binding pocket, is not visible in the electron density map
apparently due to disorder in the absence of NAD. The
loop is well defined in all four subunits in the holoen-
zyme structure as well as in the ternary complex. Ordering
of this loop increases interactions between subunits posi-
tioned across from each other in the tetramer (A:D, and
B:C subunits) and changes packing environment at the
subunit interfaces (Fig. 1B). However, there is no direct
contact between NAD and any amino acid residue in this
loop. In the holoenzyme one water molecule is involved
in bridging the pyrophosphate of the nicotinamide moi-
ety with the peptide nitrogen atom of A184 in subunits A
(W425), C (W717) and D (W379). The corresponding
oxygen and nitrogen atoms in the B subunit are ~1Å fur-
ther than in the other three subunits and no water mole-
cule could be located for bridging them. In addition, in
each subunit pair (A, D and B, C) one water molecule acts
as a bridge between the main chain oxygen atom on D190
of one subunit and the adenosine pyrophosphate group
of the NAD molecule belonging to the other subunit. In
Cofactor induced ordering of S-loop Figure 1
Cofactor induced ordering of S-loop. A: Surface drawing 
showing the packing of CpGAPDH subunits A and D in the 
apoenzyme. A loop comprising of residues 185–197 is disor-
dered in the apoenzyme structure. CpGAPDH holoenzyme 
structure in which the above mentioned loop is ordered 
(shown in cyan), is superposed on the apoenzyme structure. 
B: Surface representation of the interface between subunits 
A and D of CpGAPDH. A and D subunits of apo-CpGAPDH 
and Holo-CpGAPDH superposed. The S-loop, which is dis-
ordered in the apoenzyme structure but ordered in the 
holoenzyme, is shown as surface colored by charge (red: neg-
ative, blue: positive, green: neutral). Interactions occur 
between molecules A & D and B & C.BMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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each subunit, one or both of the carboxyl oxygen atoms of
D34 forms hydrogen bonds to the hydroxyl oxygen atoms
of adenosine ribose of NAD.
There is a significant shift in the main chain as well as side
chain of five residues (180–184) immediately preceding
the S-loop upon NAD binding. Although the movement
of the polypeptide chain is similar in all subunits, this
movement had varying effects on the active sites of indi-
vidual subunits. In subunits A and D, the side chain of
H180 moved away from its position in the apoenzyme
but in B and C it remained unchanged. In the E. coli
GAPDH, NAD binding resulted in a slight increase in the
distance between the NE2 atom of the histidine and the
thiol group of the cysteine residue in the active site. On
the contrary, the distance between the corresponding res-
idues in BsGAPDH decreased upon NAD binding. In
CpGAPDH apoenzyme the distance between the corre-
sponding atoms ranged between 4.55 and 4.93Å in differ-
ent subunits. Upon NAD binding, the distance between
the NE2 atom of H180 and SG atom of C153 decreased in
all four subunits. However, in two of the subunits (A and
D), these atoms moved more than 1.2Å closer (than in the
apoenzyme) while in the other two subunits, the move-
ment was relatively small (~0.3 and 0.2Å). Movement of
the H180 residue in A and D subunits is shown in Fig. 2A;
in B and C subunits H180 remained in the same position
(Fig. 2B). Nevertheless, upon D-G3H binding the side
chain of H180 in all subunits moves to a similar position.
Comparison of the structures of apoenzyme and holoen-
zyme reveals, in addition to ordering of the S-loop, four
other regions differ significantly: residues 35–36, 77–83,
98–103 and 180–184. Residues 35–36 are in a loop that
is close to the adenine ring of the NAD molecule. The
movement of this loop is probably required to accommo-
date the NAD molecule as well as to form better hydro-
phobic contacts with the adenine ring of NAD. Residues
77–83 are part of a surface loop that is at one end of the
NAD binding site. Movement of this loop places the main
chain oxygen of K79 within hydrogen-bonding distance
of AN6 on the NAD molecule. While the arrangement of
this loop perhaps stabilizes the binding of NAD, move-
ment of the loop 180–184 allows substrate binding.
In spite of slight differences in the local structure, the over-
all structure of the four subunits within the asymmetric
unit of the binary complex is very similar. The average
root-mean-square value obtained from the different pair-
wise superpositions of the Cα atoms is 0.2Å. However, in
the ternary complex, subunit D differs significantly from
the other three subunits in the region from residues 213
to 225. The average root-mean-square value for pair-wise
superpositions of the Cα atoms in subunits A, B and C is
0.25 Å, but the Cα positions of residues 213 to 225 in the
D subunit differ by up to 2.9 Å from the corresponding
residues in the other three subunits. In fact, this region in
the D subunit assumes a conformation that corresponds
to the structures of substrate-free CpGAPDH. The position
of NAD is virtually identical in the binary and ternary
complexes and is very similar to previously described
structures.
Glyceraldehyde 3-phosphate binding to CpGAPDH
Although a racemic mixture of L- and D-G3H was used to
prepare the ternary complex, only the D-enantiomer was
bound to each molecule of the tetramer. An active site
mutant (C153→S) was used to prepare the ternary com-
plex. In the CpGAPDH ternary complex, substrate is
bound to each subunit slightly differently than in others
revealing the flexibility of the substrate binding event in
the active site of GAPDH (Fig. 3). The quality of electron
density for D-G3H molecule in each subunit was excellent
(see Additional file 1).
Two distinct positions for the substrate have been
described in different GAPDH structures (Table 2). In
CpGAPDH subunits A, B and C the substrate binds with
the C-3 phosphate in the classical 'new Pi site' as defined
by Kim et al [17]. The phosphate oxygen atoms form
hydrogen bonds with residues G215 (N), T154 (OG1),
S152 (OG), A216 (N) and T214 (OG1) (Fig. 4A and Table
3). In subunit D, the phosphate moiety of D-G3H occu-
pies a site that does not correspond to any previously
reported phosphate binding site (Fig. 4B). The phospho-
rus atom in this subunit is ~2.6–2.8Å from the corre-
sponding position in the other three subunits. The
phosphate oxygen atoms form hydrogen bonds with resi-
dues S153 (OG), H180 (NE2), T154 (OG1) (Table 3). In
subunits A, B and C the hydroxyl oxygen atom of S152 is
involved in hydrogen bonding with the C3 phosphate
oxygen of the substrate. As in the holoenzyme this
hydroxyl oxygen also forms hydrogen bonds with the side
chain hydroxyl group of T155. In subunit D, the S152
hydroxyl group retains the hydrogen bond with T155, but
Cofactor induced conformational changes in active site histi- dine (H180) Figure 2
Cofactor induced conformational changes in active 
site histidine (H180). A: Movement of the active site histi-
dine residue in subunits A and D. Apo (white), Holo (yellow); 
B: In subunits B and C H180 remains in the same position in 
the apo and holo forms.BMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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the phosphate is oriented away from the S152 hydroxyl
oxygen.
Upon substrate binding a significant change occurs in
subunits A, B and to a lesser extent in C in the region from
residues 213 to 225, which includes the last residue in a β-
strand, two residues that connect the strand to a helix, and
the beginning of an α-helix (Fig. 5). The conformation of
this portion of the polypeptide chain appears to be deter-
mined by the presence or absence of a phosphate moiety
in the 'Pi' site (see below). In the CpGAPDH ternary com-
plex, the conformation of the polypeptide chains (in mol-
ecules A, B and C) is similar to each other and to the
structures of GAPDH from E. coli [16] and L. mexicana
[17], in which the phosphate groups occupy almost iden-
tical positions. However, this stretch of the polypeptide
chain in subunit D of the ternary complex remains in the
same conformation as in the apo and holoenzyme struc-
tures (Fig. 5D). In this subunit D-G3H molecule not only
occupies a different position from that in the other three
subunits, but it is oriented differently from any other
reported enzyme-substrate complexes (Figs. 3 and 4).
The orientation of the O2 hydroxyl group and O1 carbo-
nyl oxygen of D-G3H with respect to the active site resi-
dues (S153 and H180) varies in different subunits of
CpGAPDH tetramer. In subunit A, the O1 oxygen is
within hydrogen bonding distance of NE2 of H180 as well
as the hydroxyl oxygen atom of S153 (in the wild type
enzyme a cysteine residue is present in its place). The O2
oxygen atom forms a hydrogen bond with a water mole-
cule. In subunits B and C, the D-G3H is rotated approxi-
mately 180 about the C2-C3 bond (with respect to the
substrate in the A subunit). In both B and C subunits, the
C2 hydroxyl oxygen atom is within hydrogen bonding
distance of H180 NE2 and S153 OG. In these subunits the
O1 oxygen of the substrate forms a hydrogen bond with a
water molecule. An Fo-Fc electron density map calculated
after refinement, showed unexplained density (connect-
ing the position of the C3 atom to a neighboring water
Substrate binding in CpGAPDH subunits Figure 3
Substrate binding in CpGAPDH subunits. Stereo view 
of the substrate and active site residues (H180 and S153) 
shown in stick model in each subunit. A-D: Subunits A-D.
Comparison of the D-G3H binding sites in CpGAPDH, A and  D subunit Figure 4
Comparison of the D-G3H binding sites in 
CpGAPDH, A and D subunit. A: Subunit A of 
CpGAPDH. Stick models are shown in white and red for 
subunit A; residues that bind to the C-3 phosphate and the 
active site residues (S153 and H180) are shown as sphere. 
The C3-phosphate occupies the 'new Pi site' in A, B and C 
subunits. B: Orientation of D-G3H molecule in subunit D of 
CpGAPDH (white and red stick) is different. There is no 
interaction between the phosphate oxygens and the phos-
phate binding loop.BMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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molecule) near the D-G3H molecule in the C subunit
(Fig. 6) suggesting some movement or conformational
flexibility of this molecule. Attempts to fit an alternate
conformation of D-G3H in this density were not success-
ful. In molecule D, however, the substrate is rotated 90°
so that one of the phosphate oxygen atoms forms a hydro-
gen bond with the H180 NE2 and S153 OG. There is also
a hydrogen bond between the T154 side chain and a phos-
Table 2: GAPDH complexes with substrate or substrate analogue.
PDB number Reference NAD present Substrate No. of subunits with 
substrate
Ps or New Pi* site Soaked or 
Co-crystallized
CpGAPDH This structure Yes D-glyceraldehyde 
3-phosphate
4N e w  P i & Co-crystal
1GYP 17 Yes PO4 4 Ps and new Pi Co-crystal
1DC4 16 No D-glyceraldehyde 
3-phosphate
2# New Pi Soaked
1NQO 15 Yes D-glyceraldehyde 
3-phosphate
4P s S o a k e d
3CMC 12 Yes D-glyceraldehyde 
3-phosphate
4 New Pi Soaked
1ML3 14 Yes (3-formyl-but-3-enyl)-
phosphonic acid
3+ Ps Co-crystal
1QXS 18 Yes 1,3-biphospho-D-glyceric 
acid
1$ Ps Co-crystal
* The 'new Pi' site is defined as the site of the phosphate in 1GYP, which contains only phosphate and NAD.
&Only subunits A, B and C. The D-G3H molecule in subunit D occupies a different position that does not correspond to any previously reported 
phosphate position.
# Two subunits per asymmetric unit.
+ Two conformers in the structure. Subunit D has only conformer A, and its phosphate moiety binds in the 'Ps' site. Subunits B and C have both 
conformers at 50% occupancy; the phosphate moiety in conformer B binds in a site that is 2.5 to 2.8 Å from the 'new Pi' site.
$ Only one subunit (subunit C) binds the analogue. One of the phosphate moieties binds in the 'Ps' site. The other binds in a site that is 2.8 Å from 
the 'new Pi' site.
Table 3: Interactions between D-G3H and the active site 
residues of C153S CpGAPDH
Distance in Subunit
D-G3H Residue (atom) A B C D
O1 S153 (OG) 2.70
O1 H180 (NE2) 2.64
O1 R237 (NH2) 3.05
O1 Water (O) 2.61 2.71 2.52
O2 S153 (OG) 2.70 2.66
O2 H180 (NE2) 2.75 2.75
O2 R237 (NH2) 3.17
O2 Water (O) 2.66
O2P S153 (N) 3.11
O2P T154 (OG1) 2.65 2.70
O2P T214 (OG1) 2.84 2.75
O2P G215 (N) 2.70
O2P Water (O) 2.66 2.79 2.75 2.76
O2P Water (O) 2.97
O3P S152 (OG) 2.68
O3P T154 (OG1) 2.59
O3P T214 (OG1) 2.91 2.74
O3P G215 (N) 2.90
O3P A216 (N) 3.00
O3P Water (O) 2.82 2.66
O3P Water (O) 2.75
O4P S152 (OG) 2.49 2.70
O4P S153 (OG) 2.43
O4P H180 (NE2) 2.60
O4P T214 (O) 2.83
O4P T214 (OG1) 2.95
O4P Water (O) 2.65
O4P Water (O) 2.65
Stereo view of the substrate induced conformational change  in the phosphate binding loop Figure 5
Stereo view of the substrate induced conformational 
change in the phosphate binding loop. Movement of the 
phosphate binding loop upon substrate binding is shown. 
Structure of CpGAPDH apoenzyme (white), holoenzyme 
(cyan) and ternary complex (red) superposed on each other 
and shown as cartoon for each subunit.BMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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phate oxygen. In this subunit, the orientation of the sub-
strate places the O1 oxygen away from the active site
residues; the O2 oxygen forms a contact with side chain
nitrogen atom (NH2) of R237. The position of the sub-
strate in this subunit is clearly not suitable for catalysis
and may represent an initial (Pre-Michaelis) complex.
Comparison of the holoenzyme subunits with those in
the ternary complex reveals that upon substrate binding
the side chain of R237 residue in each subunit moves
towards the substrate.
Comparison of substrate binding
Two other structures of a ternary GAPDH complex with
NAD and D-G3H have been published (including the
recently reported thioacyl intermediate of BsGAPDH),
although there are several structures of complexes with a
substrate analogue. There is also one structure of a binary
complex that contains only the D-G3H molecule without
NAD. The NAD molecule occupies a similar position in
ternary complexes. However, the positions and conforma-
tions of the D-G3H molecules and analogues vary widely.
Table 2 lists the most relevant GADPH structures with the
substrate or substrate analog.
In the E. coli GAPDH structure [16], the phosphate moiety
of D-G3H occupies the same position as in our structure,
but the molecule is rotated along the C2-C3 bond. How-
ever, the E. coli GAPDH complex did not contain NAD,
and the position of the carbonyl oxygen in D-G3H would
not be allowed if NAD was bound in the usual position.
In two ternary complexes of BsGAPDH, the phosphate
was found to bind in the Ps site [15]. In forming these
complexes the substrate was soaked into crystals of
mutant forms of holoenzyme (active site cysteine was
mutated to alanine or serine). The substrate bound non-
covalently with the phosphate in the 'Ps' site; the C2
hydroxyl group pointed towards the main chain nitrogen
of residue 149 (Bs numbering). Orientation of the O1
oxygen in the complex with the serine mutant is suitable
for accepting hydrogen bonds from the NE2 atom of the
catalytic histidine and the hydroxyl group of the serine
residue. This complex was referred to as the 'Michaelis
complex'. More recently the crystal structure of the thioa-
cyl intermediate of BsGAPDH has been reported [12].
This complex was prepared by soaking D-G3H into a crys-
tal of holoenzyme (wild type). In this structure the C-3
phosphate of the substrate occupies the 'new Pi' site and
the substrate is oriented in a different manner than in the
previous complex.
Crystal structures of two other ternary complexes of
GAPDH containing analogues of D-G3H have been
reported. In the T. cruzi GAPDH structure with (3-formyl-
but-3-enyl)-phosphonic acid [14], three of the four subu-
nits bind the analogue in the active site, but there are two
distinct conformers of the analogue. The phosphate moi-
ety in conformer A binds in the 'Ps' site (subunit D); in
conformer B it binds in the 'Pi' site (subunits B and C).
Subunit D has only conformer A; subunits B and C have
both conformers at 50% occupancy. Orientation of O1
and O2 atoms in CpGAPDH subunits matches with some
of the conformers in this structure. The phosphate atom in
CpGAPDH (subunits A-C) is ~2.8Å from its position in
the 'Pi' site in the T. cruzi enzyme complex. In the T. cruzi
GAPDH structure with 1,3-biphospho-D-glyceric acid
[18], only one subunit binds the analogue. One of the two
phosphate moieties of the analogue occupies the 'Ps' site;
the other is about 2.9Å from the 'Pi' site.
Comparison with human GAPDH
Alignment of the CpGAPDH sequence with those of other
parasitic GAPDHs and human GAPDH shows that
CpGAPDH is very similar to Plasmodium falciparum
GAPDH [34]. Like Plasmodium GAPDH, a dipeptide
(KG) insertion after residue 193 is present. Electron den-
sity for this dipeptide, which belongs to the S-loop, was
Possible rotation or movement of the substrate in the active  site Figure 6
Possible rotation or movement of the substrate in 
the active site. 2Fo-Fc electron density map computed 
after the final cycle of refinement contoured at 1σ level (in 
blue) and Fo-Fc electron density map (3.0σ level) shown in 
pink around the substrate molecule in C subunit.BMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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excellent in all four subunits of the holoenzyme and ter-
nary complex. Pair wise sequence comparison of human
and C. parvum GAPDH sequences also showed three addi-
tional single residue insertions, K74, N127 and K144, in
the CpGAPDH sequence. These residues are at the protein
surface.
As noted in the Introduction section, the NAD binding
pocket of trypanosomal GAPDH has been targeted for
designing specific inhibitors. However, the amino acid
residues near the NAD binding pocket that allowed
exploitation of this site in trypanosomal GAPDH are con-
served in human and C. parvum GAPDH. The only resi-
dues near the NAD binding pocket of CpGAPDH which
are different in the human enzyme are M37 and N185,
corresponding to residues I38 and T184 in human
GAPDH (Fig. 7). In the holoenzyme the side chain atom
CE of M37 packs closely to the hydroxyl oxygen (O3B) of
the adenosine ribose in NAD (3.5 to 3.6Å in the four sub-
units). The CD1 atom of the corresponding residue I38 in
human GAPDH is 3.4Å from this ribose oxygen. The dis-
tance from the side chain N or O of N185 to the nearest
ribose oxygen atom at the nicotinamide end of NAD
(OD2) varies from 5.6 to 6.8  in different subunits of
CpGAPDH. Further studies will be necessary to determine
if the subtle differences in the NAD binding site of human
and CpGAPDH can be exploited for developing specific
inhibitors.
Discussion
A large number of studies on bacterial and eukaryotic
GAPDHs have been devoted to understanding the reac-
tion mechanism of these enzymes [37]. These studies have
been supplemented by a number of structural investiga-
tions in an effort to characterize the active site interactions
with the substrate and cofactor [38]. Many of these studies
have been conducted elegantly with clever tactics to cap-
ture the substrate at various stages of the reaction for
which the mechanism has been fairly well established.
However, as listed in Table 2, results of these structural
studies showed variations in the binding mode and orien-
tation of the substrate with respect to the active site resi-
dues revealing the plasticity of the GAPDH active site.
In order to capture a stable ternary complex of CpGAPDH
with NAD and the physiological substrate we used an
active site mutant that had extremely low but definite
enzymatic activity. It is important to note that there is a
major difference in the preparation of various complexes
of GAPDH. While both BsGAPDH ternary complexes
were obtained by soaking crystals of the binary complex
in a solution containing DL-G3H, the CpGAPDH ternary
complex was prepared by incubating the protein solution
with NAD and DL-G3H for 3 hrs on ice prior to setting up
crystallization. In order to maintain the phosphate bind-
ing sites unoccupied, we avoided using sulfate or phos-
phate ion during purification or crystallization. In
preparing the BsGAPDH complexes, sulfate (as ammo-
nium salt) was used either during purification or in crys-
tallization. Some of the E. coli complexes were obtained
by soaking cofactor and substrate into apo crystals.
In the non-covalent BsGAPDH/NAD/substrate complex
the C-3 phosphate is bound to the 'Ps' site, and the orien-
tation of the D-G3H molecule is appropriate for interac-
tion of the O1 atom with the NE2 atom of active site
histidine and OG of serine (substituted for cysteine). The
C-3 phosphate interacts with the side chain nitrogen atom
of R231, side chain oxygen atom of T231 and the 2'-
hydroxyl group of ribose attached to the nicotinamide
ring of NAD. The R195 side chain forms a weaker interac-
tion (3.14Å) with O3P. In the thioacyl enzyme intermedi-
ate positions of both the phosphate group and the O1
atom change. According to Moniot et al [23] this repre-
sents the binding mode after flipping of the substrate that
occurs concomitantly or after the redox step. In this struc-
ture in each subunit a sulfate ion is bound at the 'Ps' site.
The substrate molecule is partially occupied in the active
site with the C-3 phosphate binding to the 'new Pi' site
along with a sulfate ion that also partially occupies this
Stereo view of the NAD binding site Figure 7
Stereo view of the NAD binding site. Cartoon repre-
sentation of CpGAPDH (holo, subunit A) in wheat color 
superimposed on the O subunit of human GAPDH holoen-
zyme structure (PDBID: 1ZNQ) shown in white. CpGAPDH 
residues M37 and N185 are shown in stick (color coding C: 
orrange, N:blue, O: red and S: yellow) along with corre-
sponding human GAPDH residues I38 and T184(C: white, N: 
blue and O: red). NAD molecule is also shown in stick (C: 
rose, N: blue and O: red). NAD atoms nearest to M37 and 
N185 are connected with dotted lines.BMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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site. The 206–210 loop also exists in alternate conforma-
tions in forming the 'Pi' site. While the C1 atom is cova-
lently linked to the thiol group of C149, the O2 atom
forms a hydrogen bond with the nicotinamide oxygen.
The structure of the ternary complex of CpGAPDH dem-
onstrates the extremely flexible nature of the GAPDH
active site. In the A, B and C subunits, the phosphate occu-
pies the 'new Pi' site and the movement of the phosphate
binding loop is obvious. In the A subunit, there are strong
interactions between the O1 carbonyl oxygen of the sub-
strate and the active site H180 and S153 side chains as
indicated by uninterrupted electron density covering this
area of the subunit (see Additional file 1). In the B subunit
the orientation of the O1 and O2 atoms with respect to
the substrate is different with the O2 hydroxyl oxygen
now directed toward the active site residues. Electron den-
sity between the substrate and the side chains of S153 and
H180 is not continuous in this active site. In the C subunit
the electron density indicates movement (or rotation) of
the substrate (Fig. 6). However, attempts to refine multi-
ple conformations of D-G3H in this active site were not
successful. In our model, the electron density map
showed interaction of the O2 atom with both NE2 of
H180 and OG of S153. In the D subunit, the phosphate,
on the other hand, interacts with both NE2 of H180 and
OG of S153. The phosphate binding loop in this subunit
remains in the substrate-free conformation (as in the apo
and holoenzyme structures). Binding of the C3 phosphate
in the A, B, C subunits suggest that the 'new Pi' site is pre-
ferred.
The position of the C-3 phosphate in the CpGAPDH struc-
ture (A, B and C subunits) is in agreement with several
other structural studies, including the structure of the
BsGAPDH in complex with the substrate analog glycidol
3-phosphate (and NAD) [19], and the structure of E. coli
GAPDH in complex with D-G3H (and no NAD) [16]. In
both structures, the C-3 phosphate group is located in the
'new Pi' site. Each subunit of CpGAPDH contains a fully
occupied NAD molecule. Therefore, the preference of the
C3 phosphate in the 'new Pi' site is not due to the lack of
integrity (or completeness) of the 'Ps' site as was suggested
to be the case for E. coli GAPDH.
Comparison of the structure of T. cruzi GAPDH in the
holo form and in the apo form in complex with an inhib-
itor showed major structural changes were related to the
orientation of residue R249 (T. cruzi numbering). In the
absence of substrate (or analogue) or anion in the active
site, the side chain of R249 points to D210. At the same
time the distance between the NE2 atom of the active site
histidine and the SG atom of the active site cysteine
increased upon binding of the substrate analogue. In all
subunits of CpGAPDH the distance between the arginine
(R237) and aspartate (D198) residues increased signifi-
cantly upon substrate binding. In each subunit of the ter-
nary complex R237 points towards T183, and the contact
distance between the side chain nitrogen atom of R237
and OG1 atom of T213 ranges from 2.60 to 3.19Å.
In the ternary complex the distance between H180NE2
and S153OG in different subunits varied in the range of
4.11–4.23Å. The corresponding distances in the
BsGAPDH non-covalent complex were very similar to the
latter distances (4.08–4.31Å) suggesting that the active
site residues were perfectly positioned for the formation
of the productive complex in each subunit of CpGAPDH.
Conclusion
Structural data on GAPDHs in complex with substrate and
substrate analogs demonstrate extraordinary plasticity of
the active site. It is evident from these studies that the
active site can accommodate the substrate in a variety of
positions and conformations (Fig. 8). Direct comparisons
of the available structures are not always straightforward
due to the differences in the composition of the samples
and conditions used for crystallization. In particular, the
presence of sulfate (or phosphate) ions in the purification
and crystallization media for some of these complexes
changes the charge distribution and binding environ-
ment. For example, sulfate ions are located in the 'Pi' sites
in the thioacyl derivative of BsGAPDH/NAD/D-G3H
complex (Fig. 8). How these ions influence the binding
Flexibility in substrate binding at the GAPDH active site  (stereo) Figure 8
Flexibility in substrate binding at the GAPDH active 
site (stereo). Position of D-G3H in the CpGAPDH ternary 
complex subunit A (yellow), subunit D (wheat); mutant 
BsGAPDH ternary complex (PDBId: 1nqo) subunit O (pale 
cyan); BsGAPDH thiacyl intermediate (PDBId: 3cmc) subunit 
O (light green); E. coli GAPDH (1dc4) subunit O (light pink). 
The 'Ps' and 'new Pi' sites are indicated. A sulfate ion is 
bound in each subunit of the BsGAPDH complex.BMC Structural Biology 2009, 9:9 http://www.biomedcentral.com/1472-6807/9/9
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and movement of the substrate in the active site is not
clear. However, structure of the ternary complex of
CpGAPDH presented here clearly shows preference of the
C3-phosphate for the 'new Pi' site for binding. Moreover,
the presence of multiple conformations of D-G3H in var-
ious structures and in different subunits of CpGAPDH
also demonstrates the flexibility and movement of the
substrate even when the C-3 phosphate is bound at the
'new Pi' site.
The atomic coordinates and structure factors for
CpGAPDH structures have been deposited with the
Brookhaven Protein Data Bank (PDBIds: 3CHZ, 3CIE and
3CIF).
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